Martijn S. Rutten
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Hepatocyte-specific Cas9-mediated editing of G6pc and Slc37a4 elicits comparable biochemical and regulatory responses between glycogen storage disease (GSD) type Ia and Ib mice.
Journal: Molecular metabolism
Published: October 24, 2025
Sport and longevity: an observational study of international athletes.
Journal: GeroScience
Published: June 10, 2024
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia.
Journal: Cancer & metabolism
Published: January 25, 2023
C/EBPβ-LIP mediated activation of the malate-aspartate shuttle sensitizes cells to glycolysis inhibition.
Journal: Molecular metabolism
Published: January 18, 2023
Functional Validation of the Putative Oncogenic Activity of PLAU.
Journal: Biomedicines
Published: November 24, 2022
Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial.
Journal: European heart journal
Published: October 12, 2022
Increased atherosclerosis in a mouse model of glycogen storage disease type 1a.
Journal: Molecular genetics and metabolism reports
Published: April 15, 2022
Dynamic Methods for Childhood Hypoglycemia Phenotyping: A Narrative Review.
Journal: Frontiers in endocrinology
Published: January 20, 2022
Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
Journal: Molecular metabolism
Published: April 09, 2021
Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR-associated protein 9-Mediated Gene Editing.
Journal: Hepatology (Baltimore, Md.)
Published: September 29, 2020
Last Updated: 09/26/2026